-
1دورية أكاديمية
المؤلفون: Cescon, David W, Schmid, Peter, Rugo, Hope S, Im, Seock-Ah, Yusof, Mastura Md., Gallardo, Carlos, Lipatov, Oleg, Barrios, Carlos H, Perez-Garcia, Jose, Iwata, Hiroji, Masuda, Norikazu, Otero, Marco Torregroza, Gokmen, Erhan, Loi, Sherene, Haiderali, Amin, Zhou, Xuan, Guo, Zifang, Nguyen, Allison Martin, Cortes, Javier
المصدر: JNCI: Journal of the National Cancer Institute; May2024, Vol. 116 Issue 5, p717-727, 11p
مصطلحات موضوعية: TRIPLE-negative breast cancer, QUALITY of life, PEMBROLIZUMAB, PHYSICAL mobility, HORMONE receptor positive breast cancer, CANCER chemotherapy
-
2دورية أكاديمية
المؤلفون: Cortes, Javier, Winer, Eric P, Lipatov, Oleg, Im, Seock‐Ah, Gonçalves, Anthony, Muñoz‐Couselo, Eva, Lee, Keun Seok, Schmid, Peter, Tamura, Kenji, Testa, Laura, Witzel, Isabell, Ohtani, Shoichiro, Hund, Stephanie, Kulangara, Karina, Karantza, Vassiliki, Mejia, Jaime A, Ma, Junshui, Jelinic, Petar, Huang, Lingkang, Pruitt, Scott K
المصدر: Journal of Pathology: Clinical Research; May2024, Vol. 10 Issue 3, p1-10, 10p
مصطلحات موضوعية: TRIPLE-negative breast cancer, PROGRAMMED death-ligand 1, BIOMARKERS, RECEIVER operating characteristic curves
-
3دورية أكاديمية
المؤلفون: Li, Rubi K., Tokunaga, Eriko, Adamchuk, Hryhoriy, Vladimirov, Vladimir, Yanez, Eduardo, Lee, Keun Seok, Bondarenko, Igor, Vana, Alicia, Hilton, Fiona, Ishikawa, Tomofumi, Tajima, Kentaro, Lipatov, Oleg
المصدر: BioDrugs; Jan2022, Vol. 36 Issue 1, p55-69, 15p
مصطلحات موضوعية: HER2 positive breast cancer, METASTATIC breast cancer, EPIDERMAL growth factor receptors, TRASTUZUMAB
الشركة/الكيان: EUROPEAN Union
-
4دورية أكاديمية
المؤلفون: Candelaria, Myrna, González, Derlis E., Delamain, Marcia Torresan, Bär, Daniel Oscar, Beniwal, Surender Kumar, Dasappa, Lokanatha, Flores, David Hugo, Querol, John, Guan, Toh See, Lipatov, Oleg Nikolaevich, Volodicheva, Elena Mikhailovna, Patel, Moosa, Safaee Nodehi, Sayyed Reza, Fogliatto, Laura, Paravisini, Alexandra, Perez Diaz, Luis
المصدر: Leukemia & Lymphoma; Dec2019, Vol. 60 Issue 14, p3375-3385, 11p
مصطلحات موضوعية: RITUXIMAB, LYMPHOMAS, CANCER treatment, THERAPEUTICS, ADVERSE health care events